Cannformatics to Announce Dementia and Medical Cannabis Study at the 2nd Annual New York State Medical Cannabis Symposium

Study evaluating cannabinoids in dementia to be conducted at Northwell Health receives IRB approval; Cannformatics to present on Friday, November 7 SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- Cannformatics Inc., a biotechnology company advancing the use of metabolic biomarkers and...

Read More